Javascript must be enabled to continue!
From CML to a Model-Based Concurrent Specification Language
View through CrossRef
In this paper, we address the problem of specification and design of concurrent systems More accurately, we present the definition of a new specification language that is formal, wide-spectrum, model-based, concurrent, polymorphic, and strongly implicitly typed The lan guage is built upon a concurrent, functional, and imperative programming language Concurrent ML Specification aspects are supported thanks to the addition of some specification constructs and also by allowing axioms to appear in ML structures and signatures The resulting specification language is thus highly expressive though it embodies a restricted number of concepts We present here the motivations underlying the definition of such a language as well as the design choices Furthermore, we introduce the specification and development methodology and illustrate it on various examples We will see that many specification styles are allowed algebraic, applicative, state-based, concurrent applicative, and con current imperative
Title: From CML to a Model-Based Concurrent Specification Language
Description:
In this paper, we address the problem of specification and design of concurrent systems More accurately, we present the definition of a new specification language that is formal, wide-spectrum, model-based, concurrent, polymorphic, and strongly implicitly typed The lan guage is built upon a concurrent, functional, and imperative programming language Concurrent ML Specification aspects are supported thanks to the addition of some specification constructs and also by allowing axioms to appear in ML structures and signatures The resulting specification language is thus highly expressive though it embodies a restricted number of concepts We present here the motivations underlying the definition of such a language as well as the design choices Furthermore, we introduce the specification and development methodology and illustrate it on various examples We will see that many specification styles are allowed algebraic, applicative, state-based, concurrent applicative, and con current imperative.
Related Results
Hubungan Perilaku Pola Makan dengan Kejadian Anak Obesitas
Hubungan Perilaku Pola Makan dengan Kejadian Anak Obesitas
<p><em><span style="font-size: 11.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-langua...
Safety and Efficacy of Tgrx-678, a Potent BCR-ABL Allosteric Inhibitor in Patients with Tyrosine Kinase Inhibitor (TKI) Resistant/Refractory Chronic Myeloid Leukemia (CML): Preliminary Results of Phase I Study
Safety and Efficacy of Tgrx-678, a Potent BCR-ABL Allosteric Inhibitor in Patients with Tyrosine Kinase Inhibitor (TKI) Resistant/Refractory Chronic Myeloid Leukemia (CML): Preliminary Results of Phase I Study
Background:
TGRX-678 is a novel allosteric inhibitor of ABL kinases, specifically targeting the ABL Myristoyl Pocket (STAMP). In vitro data supports TGRX-678 targeti...
Characteristics of regional epidemiological indicators of chronic myeloproliferative neoplasms
Characteristics of regional epidemiological indicators of chronic myeloproliferative neoplasms
Background. Information on the epidemiological picture of chronic myeloid leukemia (CML) and, especially, Ph– chronic myeloproliferative neoplasm (MPN) in Russia is very scarce, ea...
Preferentially expressed genes in chronic myelogenous leukemia
Preferentially expressed genes in chronic myelogenous leukemia
Abstract
The predominant circulating cells in chronic myelogenous leukemia (CML) morphologically resemble normal myeloid precursors; however, certain characteristics...
CAR-macrophages targets CD26 to eliminate chronic myeloid leukemia stem cells
CAR-macrophages targets CD26 to eliminate chronic myeloid leukemia stem cells
Abstract
Background
Chronic myeloid leukemia stem cells (CML-LSCs), which exhibit resistance to tyrosine kinase inhibitors (TKIs), are the leadin...
Targeting of plasminogen activator inhibitor-1 activity promotes elimination of chronic myeloid leukemia stem cells
Targeting of plasminogen activator inhibitor-1 activity promotes elimination of chronic myeloid leukemia stem cells
Therapeutic strategies that target leukemic stem cells (LSCs) provide potential advantages in the treatment of chronic myeloid leukemia (CML). Here, we show that selective blockade...
Detection of Compound BCR-ABL Mutations in TKI Resistant CML Patients Including a Novel K245N Mutation Associated with Primary Nilotinib Resistance By Employing a Newly Developed Cost Effective BCR-ABL Sequencing Protocol
Detection of Compound BCR-ABL Mutations in TKI Resistant CML Patients Including a Novel K245N Mutation Associated with Primary Nilotinib Resistance By Employing a Newly Developed Cost Effective BCR-ABL Sequencing Protocol
Abstract
Introduction: BCR-ABL mutations are the major background players in manifestation of resistance to all FDA approved tyrosine kinase inhibitors (TKIs) includ...
TRIM28 Facilitates Chronic Myeloid Leukemia Progression By Enhancing Sumoylation and Stability of BCR-ABL
TRIM28 Facilitates Chronic Myeloid Leukemia Progression By Enhancing Sumoylation and Stability of BCR-ABL
Chronic myeloid leukemia (CML) is a hematopoietic malignancy caused by the BCR-ABL fusion gene. Although tyrosine kinase inhibitors (TKIs) targeting the oncoprotein BCR-ABL have dr...

